PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research on killer HIV antibodies provides promising new ideas for vaccine design

2010-09-30
(Press-News.org) New discoveries about the immune defenses of rare HIV patients who produce antibodies that prevent infection suggest a novel direction for designing new vaccines. Researchers at Rockefeller University and colleagues have now made two fundamental discoveries about the so called broadly neutralizing anti-HIV antibodies, which effectively keep the virus at bay. By detailing the molecular workings of a proven immune response, the researchers hope their work will ultimately enable them to similarly arm those who are not equipped with this exceptional immunological firepower. The findings are reported in the Sept. 30 issue of the journal Nature.

"Nobody yet can make a vaccine that elicits these broadly neutralizing antibodies, but here are patients who can do it, so let's understand how," says Michel C. Nussenzweig, Sherman Fairchild Professor and head of the Laboratory of Molecular Immunology. "That's the theme in this work. The reason the research community is not making this vaccine is not that we're not good engineers. We are. The reason is that we don't understand how these patients produce these antibodies, and that's what we're figuring out. If we know how they're doing it, we might learn how to reproduce it."

HIV strains mutate rapidly, making them notoriously evasive targets for the immune system. In particular, the HIV envelope spike, called gp160, is the site of a host of mutations that obstruct the few elements that all of the virus strains share. Prior research has shown that only four super antibodies block the activity of that protein in a broad range of HIV strains, neutralizing the virus. But all attempts to coax the human body into producing those four have failed.

Last year, in experiments reported in Nature, the Nussenzweig lab showed that a diverse group of broadly neutralizing antibodies cloned from 433 B cells of six slow progressing HIV patients were as capable of knocking down a broad range of HIV strains as any one of the super antibodies. The ability to isolate and clone antibodies from B cells was first worked out by the lab in a pioneering 2003 paper in Science. Now, having applied that method to the B cells in HIV patients with high titers of broadly neutralizing antibodies, the new research explores in more detail what their antibodies target and how they attack.

In work to be published Sept. 30 in Nature, postdoc Hugo Mouquet, Nussenzweig and colleagues found a surprising result. Most antibodies are traditionally thought to bind to their target, or antigen, in a bivalent fashion, meaning they get a firm grip by taking hold of two specific handles. But HIV virions do not allow for that possibility because the gp160 spikes are too far apart. Therefore, antibodies to the virus are handicapped because they can only use one of their two high affinity arms to recognize the viral spike. The researchers found that on average 75 percent of the anti-gp160-HIV antibodies in their large collection were selected by the immune system for polyreactivity, a property that allowed the second "free" arm of the antibody to enhance overall affinity by binding to the virion "non-specifically." Generally, the immune system weeds out polyreactive antibodies, even though they are naturally produced in significant quantities, because polyreactive antibodies could in theory attack the body itself.

But the experiments suggest that these "sticky" antibodies may be an opportunistic adaptation to difficult cases such as HIV, in which homotypic bivalent bonding may not be an option. This particular cadre of polyreactive antibodies takes a long time – years – to develop in slow progressing HIV patients, and much remains to be discovered about that process, but the researchers believe that vaccine designed to elicit antibodies that mimic these properties could be a promising strategy to beat the deadly virus.

In related research published in August in The Journal of Experimental Medicine, visiting student John Pietzsch, Nussenzweig and colleagues mapped the target of the largest single group of neutralizing antibodies found in HIV-infected patients with broadly neutralizing serologic activity. These antibodies including one of the recently described super antibodies, targeted a previously undefined region of the HIV envelope protein, a region that is nearby but distinct from the site targeted by previously described super antibodies. By mutating individual amino acids of this target and discovering that the result was an impotent virus, they showed that the largest group of broadly neutralizing antibodies targets a region on the HIV envelope spike that is indispensable for infection.

"The largest group of the HIV neutralizing antibodies was unmapped – this group might have been specific for a number of different sites on the virion," Nussenzweig says. "But they are directed to a single core epitope on the viral spike, near the CD4 binding site. Our findings extend the footprint of what a neutralizing antibody can see."

This site, a core element of the HIV envelope spike that is shared by a full range of HIV strains, is an attractive new target that should be considered for vaccine design, the scientists say, and they are working on how to attack it. Nussenzweig, whose lab has only in the last couple of years begun working on HIV antibodies, says, "We're making basic discoveries about how antibodies work by studying a disease in patients. We could not do this work in a model organism."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Increased risk of other cancers for relatives of women with early onset breast cancer

2010-09-30
Close relatives of women diagnosed with breast cancer before the age of 35 years are at an increased risk of developing other cancers, according to a University of Melbourne study, published in the British Journal of Cancer today. Professor John Hopper, Director of Research from the Centre for Molecular, Environmental, Genetic and Analytic Epidemiology at the University of Melbourne, Australia, a lead investigator in the study, said these are surprising and novel findings which could be pointing to the existence of a new cancer genetic syndrome. "The results suggest ...

Diet when young affects future food responses

2010-09-30
A high protein diet during development primes the body to react unhealthily to future food binges. A study on juvenile rats, published in BioMed Central's open access journal Nutrition and Metabolism, suggests that lasting changes result from altering the composition of the first solid food that is consumed throughout growth into early adulthood. Raylene Reimer worked with a team of researchers from the University of Calgary, Canada, to carry out the weaning experiments in 18 litters of rats. Six litters were placed on each of three diets: high prebiotic fiber, high ...

Newly discovered planet may be first truly habitable exoplanet

2010-09-30
SANTA CRUZ, CA--A team of planet hunters led by astronomers at the University of California, Santa Cruz, and the Carnegie Institution of Washington has announced the discovery of an Earth-sized planet (three times the mass of Earth) orbiting a nearby star at a distance that places it squarely in the middle of the star's "habitable zone," where liquid water could exist on the planet's surface. If confirmed, this would be the most Earth-like exoplanet yet discovered and the first strong case for a potentially habitable one. To astronomers, a "potentially habitable" planet ...

A 'giant' step toward explaining differences in height

2010-09-30
Boston, Mass. -- An international collaboration of more than 200 institutions, led by researchers at Children's Hospital Boston, the Broad Institute, and a half-dozen other institutions in Europe and North America, has identified hundreds of genetic variants that together account for about 10 percent of the inherited variation of height among people. Known as the GIANT (Genetic Investigation of ANthropometric Traits) Consortium, the collaboration pooled data from more than 180,000 individuals, including millions of genetic results from each of 46 separate studies in the ...

Potentially habitable planet discovered

2010-09-30
Washington, D.C. Astronomers have found a new, potentially habitable Earth-sized planet. It is one of two new planets discovered around the star Gliese 581, some 20 light years away. The planet, Gliese 581g, is located in a "habitable zone"—a distance from the star where the planet receives just the right amount of stellar energy to maintain liquid water at or near the planet's surface. The 11- year study, published in the Astrophysical Journal and posted online at arXiv.org, suggests that the fraction of stars in the Milky Way harboring potentially habitable planets could ...

New drug offers big relief for osteoarthritis pain

2010-09-30
CHICAGO --- A phase II clinical trial of the first new type of drug for musculoskeletal pain since aspirin shows that it significantly reduces knee pain in osteoarthritis, the most common osteoarthritis pain, according to new research from Northwestern Medicine. However, phase III trials of that drug, tanezumab, have been placed on clinical hold after 16 out of several thousand participants in the new trial developed progressively worsening arthritis and bone changes that required total joint replacements. "The bottom line is this is a very effective drug for relieving ...

Albert Einstein College of Medicine researcher among global team investigating genetics of height

2010-09-30
September 29, 2010 ─ (BRONX, NY) ─ A seemingly simple inherited trait – height – springs from hundreds of genetic causes, according to an international team of scientists. Robert Kaplan, Ph.D., professor of epidemiology & population health at Albert Einstein College of Medicine of Yeshiva University, is co-author of a paper on the group's findings published in the September 29 online edition of Nature. The study identified hundreds of gene variants in at least 180 locations that influence adult height. These results prove that with internet technology it ...

3 tiny qubits, another big step toward quantum computing

2010-09-30
New Haven, Conn.—The rules that govern the world of the very small, quantum mechanics, are known for being bizarre. One of the strangest tenets is something called quantum entanglement, in which two or more objects (such as particles of light, called photons) become inextricably linked, so that measuring certain properties of one object reveals information about the other(s), even if they are separated by thousands of miles. Einstein found the consequences of entanglement so unpalatable he famously dubbed it "spooky action at a distance." Now a team led by Yale researchers ...

Phase II study finds tanezumab reduces osteoarthritis knee pain

2010-09-30
(SACRAMENTO, Calif.) — Just months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee, the results of a small, phase II clinical trial found only a few minor side effects and substantial improvement in patient conditions. The results of the 16-week study are published in the Sept. 30 issue of The New England Journal of Medicine. Other, longer-term studies have indicated that tanezumab may accelerate osteoarthritis, and the company that manufactures the ...

Study finds first direct evidence that ADHD is a genetic disorder

2010-09-30
Research published today provides the first direct evidence that attention-deficit/hyperactivity disorder (ADHD) is a genetic condition. Scientists at Cardiff University found that children with ADHD were more likely to have small segments of their DNA duplicated or missing than other children. The study also found significant overlap between these segments, known as copy number variants (CNVs), and genetic variants implicated in autism and schizophrenia, proving strong evidence that ADHD is a neurodevelopmental disorder – in other words, that the brains of children ...

LAST 30 PRESS RELEASES:

One in 20 people in Canada skip doses, don’t fill prescriptions because of cost

Wildlife monitoring technologies used to intimidate and spy on women, study finds

Around 450,000 children disadvantaged by lack of school support for color blindness

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

[Press-News.org] Research on killer HIV antibodies provides promising new ideas for vaccine design